Important announcement concerning Temple Health and Keystone First. Our provider agreement with Keystone First, is scheduled to end on July 31st. Learn about your options to continue receiving care at Temple Health.
Trial Helps Determine Optimal Dose of Next-Generation Drug for Acute Myeloid Leukemia
Jean-Pierre Issa, MD, former director of the Fels Institute for Cancer Research and Molecular Biology at the Lewis Katz School of Medicine, Temple University, recently published the results of a phase 2 study comparing the safety and efficacy of two differe...
Read More![Link to](/sites/default/files/styles/card/public/images/blog/thumb/issa_profile.jpg?h=29bb14f2&itok=uZKF1eOi)
Trial Helps Determine Optimal Dose of Next-Generation Drug for Acute Myeloid Leukemia
Patients Needed for New Multiple Myeloma Study
In addition to excellent clinical care, Fox Chase Cancer Center is home to a team of world-renowned cancer researchers who develop and test therapies not available anywhere else. For more than a century, Fox Chase has been a key contributor in advancing und...
Read More![Link to](/sites/default/files/styles/card/public/images/blog/thumb/Fung-h_portrait.jpg?h=f192712f&itok=u1aLcBxb)
Patients Needed for New Multiple Myeloma Study
A New Phase 1 Clinical Trial for Non-Small Cell Lung Cancer
As a National Cancer Institute (NCI)-designated Comprehensive Cancer Center, Fox Chase Cancer Center offers our patients the most advanced treatment options through clinical trials, many of which are not readily available elsewhere. Our nationally ranked do...
Read More![Link to](/sites/default/files/styles/card/public/images/blog/thumb/thumb_research_microscope01_3.jpg?h=7f412c8f&itok=TiB3-8oN)
A New Phase 1 Clinical Trial for Non-Small Cell Lung Cancer
A New Stage 4 Clinical Trial for Colorectal Cancer
As a National Cancer Institute (NCI)-designated Comprehensive Cancer Center, Fox Chase Cancer Center offers our patients the most advanced treatment options through clinical trials, many of which are not readily available elsewhere. Our nationally ranked do...
Read More![Link to](/sites/default/files/styles/card/public/colon.cancer.jpg?h=2240b8e9&itok=6c99fBkn)
A New Stage 4 Clinical Trial for Colorectal Cancer
A New Stage 2-4 Clinical Trial for HIV-associated Hodgkin Lymphoma
As a National Cancer Institute (NCI)-designated Comprehensive Cancer Center, Fox Chase Cancer Center offers our patients the most advanced treatment options through clinical trials, many of which are not readily available elsewhere. Our nationally ranked do...
Read More![Link to](/sites/default/files/styles/card/public/images/blog/thumb/thumb_research_microscope01_2.jpg?h=7f412c8f&itok=qf3GOwju)
A New Stage 2-4 Clinical Trial for HIV-associated Hodgkin Lymphoma
New phase 2 clinical trial for patients with locally advanced or metastatic sarcoma
As a National Cancer Institute (NCI)-designated Comprehensive Cancer Center, Fox Chase Cancer Center offers our patients the most advanced treatment options through clinical trials, many of which are not readily available elsewhere. Our nationally ranked do...
Read More![Link to](/sites/default/files/styles/card/public/images/blog/thumb/thumb_research_microscope01_1.jpg?h=7f412c8f&itok=Xuk4tnQk)
New phase 2 clinical trial for patients with locally advanced or metastatic sarcoma
Share
-
Share with Facebook
-
Share with twitter
-
Share with email
-
Print this